Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure

American Heart Journal

Volumn 159, Issue 1, 2010, Pages 81-89

  Peterson, Pamela N ^a,b,c   Magid, David J ^b,c   Lyons, Ella E ^c   Clarke, Christina L ^c   Zeng, Chan ^c   Fitzgerald, Ashley ^b   Lindenfeld, JoAnn ^b   Kosiborod, Mikhail ^d   Brand, David ^c   Masoudi, Frederick A ^a,b,c  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c KAISER PERMANENTE   (United States)

^d SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SURVEILLANCE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANEMIA; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HEMOGLOBINS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 72149089881     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.029     Document Type: Article

References (24)

1. Tang Y.D., and Katz S.D. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113 (2006) 2454-2461
2. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 149 (2005) 391-401
3. Go A.S., Yang J., Ackerson L.M., et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113 (2006) 2713-2723
4. Dunlay S.M., Weston S.A., Redfield M.M., et al. Anemia and heart failure: a community study. Am J Med 121 (2008) 726-732
5. Kosiborod M., Smith G.L., Radford M.J., et al. The prognostic importance of anemia in patients with heart failure. Am J Med 114 (2003) 112-119
6. Kosiborod M., Curtis J.P., Wang Y., et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 165 (2005) 2237-2244
7. Groenveld H.F., Januzzi J.L., Damman K., et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol 52 (2008) 818-827
8. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-summary article. Circulation 112 (2005) 1825-1852
9. Knmler T., Gislason G.H., Kirk V., et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 10 (2008) 658-660
10. Lee D.S.M., Donovan L.M., Austin P.C.P., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 43 (2005) 182-188
11. Schrier S.L. It's tough to be old and anemic. Blood 104 (2004) 2214-2215
12. O'Quigley J., Xu R., and Stare J. Explained randomness in proportional hazards models. Stat Med 24 (2005) 479-489
13. Allison P.D. Survival analysis using the SAS system (2005), SAS Institute INC, Cary (NC)
14. Jones B.L., Nagin D.S., and Roeder K.A. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 29 (2001) 374-393
15. Helgeson V.S., Snyder P., and Seltman H. Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 23 (2004) 3-15
16. Clark D.B., Jones B.L., Wood D.S., et al. Substance use disorder trajectory classes: diachronic integration of onset age, severity, and course. Addict Behav 31 (2006) 995-1009
17. Lin D., Wei L., and Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80 (1993) 557-572
18. Anand I.S., Kuskowski M.A., Rector T.S., et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112 (2005) 1121-1127
19. Masoudi F.A., Havranek E.P., Smith G., et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41 (2003) 217-223
20. Tang W.H.W., Tong W., Jain A., et al. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 51 (2008) 569-576
21. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
22. Mancini D.M., Katz S.D., Lang C.C., et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
23. Toblli J.E., Lombrana A., Duarte P., et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50 (2007) 1657-1665
24. Okonko D.O., Grzeslo A., Witkowski T., et al. Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency: FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 (2008) 103-112